Comments: US HB7667 | 2021-2022 | 117th Congress

Bill Title: Biosimilar User Fee Amendments of 2022 Generic Drug User Fee Amendments of 2022 Prescription Drug User Fee Amendments of 2022 Medical Device User Fee Amendments of 2022

Spectrum: Bipartisan Bill

Status: (Engrossed - Dead) 2022-06-09 - Received in the Senate. [HB7667 Detail]

Text: Latest bill text (Engrossed) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2021 US Congress HB7667 at this time.

Social Comments on US HB7667

feedback